title: Impairment of glycosyl-phosphatidylinositol-dependent insulin signaling system in isolated rat hepatocytes by streptozotocin-induced diabetes.
abstract: The addition to different types of cells of an inositol-phosphate glycan, generated by the phospholipase C-catalyzed hydrolysis of a insulin-sensitive glycosyl-phosphatidylinositol (glycosyl-PI), mimics some of the biological effects of this hormone. Recently, a specific, time-, dose-, and energy-dependent transport system for this inositol-phosphate glycan has been identified in isolated rat hepatocytes. Here, we show that streptozotocin-induced diabetes mellitus reduced (by about 60%) the basal content of the insulin-sensitive glycosyl-PI in isolated rat hepatocytes. Moreover, streptozotocin-induced diabetes blocked the hydrolysis of the glycosyl-PI in response to insulin, diminished inositol phosphate-glycan uptake by the hepatocytes, and abolished the stimulatory effect of this compound on glycogen synthesis. All these metabolic changes caused by streptozotocin administration were reversed by treatment of the animals with insulin. Our results support the hypothesis that insulin resistance in streptozotocin-induced diabetic rats is related to the impairment of glycosyl-PI metabolism.
authors.affiliation: Servicio de Endocrinología Experimental, Hospital Puerta de Hierro, Universidad Autónoma de Madrid, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Sanchez-Arias
authors.forename: J C
authors.initials: JC
authors.lastname: Sanchez-Gutierrez
authors.forename: A
authors.initials: A
authors.lastname: Guadaño
authors.forename: J F
authors.initials: JF
authors.lastname: Alvarez
authors.forename: B
authors.initials: B
authors.lastname: Samper
authors.forename: J M
authors.initials: JM
authors.lastname: Mato
authors.forename: J E
authors.initials: JE
authors.lastname: Feliu
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000502:physiology; D002469:Cell Separation; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism* / Q000473:pathology; D017261:Glycosylphosphatidylinositols / Q000502:physiology*; D007294:Inositol / Q000031:analogs & derivatives / Q000276:immunology; D007295:Inositol Phosphates / Q000037:antagonists & inhibitors / Q000493:pharmacokinetics / Q000494:pharmacology; D007328:Insulin / Q000502:physiology*; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D011134:Polysaccharides / Q000037:antagonists & inhibitors / Q000276:immunology / Q000493:pharmacokinetics / Q000494:pharmacology; D051381:Rats; D015398:Signal Transduction
chemical_list: D000906:Antibodies; D017261:Glycosylphosphatidylinositols; D007295:Inositol Phosphates; D007328:Insulin; D011134:Polysaccharides; C028039:inositol phosphate glycan; C068698:inositol-glycan; D007294:Inositol